Free Trial

Deltex Medical Group (DEMG) Competitors

GBX 0.09
-0.01 (-5.26%)
(As of 11/1/2024 07:39 PM ET)

DEMG vs. RUA, MHC, SUN, SN, MXCT, NIOX, EKF, CREO, IUG, and NCYT

Should you be buying Deltex Medical Group stock or one of its competitors? The main competitors of Deltex Medical Group include RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Smith & Nephew (SN), MaxCyte (MXCT), NIOX Group (NIOX), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), and Novacyt (NCYT). These companies are all part of the "medical devices" industry.

Deltex Medical Group vs.

Deltex Medical Group (LON:DEMG) and RUA Life Sciences (LON:RUA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Deltex Medical Group has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, RUA Life Sciences has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

In the previous week, Deltex Medical Group's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company Overall Sentiment
Deltex Medical Group Neutral
RUA Life Sciences Neutral

RUA Life Sciences has a net margin of -65.72% compared to Deltex Medical Group's net margin of -72.49%. RUA Life Sciences' return on equity of -24.27% beat Deltex Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Deltex Medical Group-72.49% -57.02% -7.77%
RUA Life Sciences -65.72%-24.27%-17.50%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Deltex Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
RUA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

18.9% of Deltex Medical Group shares are owned by institutional investors. Comparatively, 26.0% of RUA Life Sciences shares are owned by institutional investors. 67.7% of Deltex Medical Group shares are owned by company insiders. Comparatively, 51.3% of RUA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Deltex Medical Group received 59 more outperform votes than RUA Life Sciences when rated by MarketBeat users. Likewise, 64.84% of users gave Deltex Medical Group an outperform vote while only 0.00% of users gave RUA Life Sciences an outperform vote.

CompanyUnderperformOutperform
Deltex Medical GroupOutperform Votes
59
64.84%
Underperform Votes
32
35.16%
RUA Life SciencesOutperform Votes
No Votes
Underperform Votes
6
100.00%

Deltex Medical Group has higher earnings, but lower revenue than RUA Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deltex Medical Group£1.78M0.96-£1.29MN/AN/A
RUA Life Sciences£2.19M3.28-£1.44M-£0.04-289.25

Summary

Deltex Medical Group and RUA Life Sciences tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DEMG vs. The Competition

MetricDeltex Medical GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£1.71M£1.79B£5.02B£1.40B
Dividend Yield2.19%2.48%7.49%11.78%
P/E Ratio-5.75195.22128.481,561.46
Price / Sales0.96191.871,723.16209,782.91
Price / Cash9.0015.5136.9032.90
Price / BookN/A3.364.592.85
Net Income-£1.29M£66.48M£113.94M£153.09M
7 Day PerformanceN/A-0.37%110.64%4.74%
1 Month PerformanceN/A-2.49%124.65%3.34%
1 Year PerformanceN/A38.03%155.07%106.65%

Deltex Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DEMG
Deltex Medical Group
N/AGBX 0.09
-5.3%
N/A-37.9%£1.71M£1.78M-5.7537Gap Down
RUA
RUA Life Sciences
N/AGBX 12.60
+0.8%
N/A-5.0%£7.82M£2.19M-315.0048Gap Down
MHC
MyHealthChecked
N/AGBX 12.50
-5.7%
N/A+10.9%£6.50M£9.39M-625.0016Gap Down
SUN
Surgical Innovations Group
N/AGBX 0.55
-1.4%
N/A-41.4%£5.13M£12.54M-21.1180Gap Down
SN
Smith & Nephew
3.4266 of 5 stars
GBX 1,103
+1.4%
GBX 3,956.20
+258.7%
+0.5%£9.62B£5.64B4,085.1918,452High Trading Volume
MXCT
MaxCyte
N/AGBX 272.90
-4.2%
N/A-0.7%£286.79M£45.44M-1,049.6280
NIOX
NIOX Group
N/AGBX 62.80
+1.6%
N/A-5.7%£266.35M£39M3,140.0092
EKF
EKF Diagnostics
N/AGBX 26.96
+2.9%
N/A-4.9%£122.32M£50.95M2,695.90356Gap Down
High Trading Volume
CREO
Creo Medical Group
N/AGBX 19.95
-0.3%
N/A-40.5%£72.18M£30.30M-332.50279Gap Down
IUG
Intelligent Ultrasound Group
N/AGBX 11
-3.3%
N/A+17.3%£35.97M£9.88M-1,100.0065Gap Down
NCYT
Novacyt
N/AGBX 50.12
-8.7%
N/A+9.2%£35.40M£18.56M-96.38120Gap Down

Related Companies and Tools


This page (LON:DEMG) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners